Abstract
Many chemical toxicants and/or their active metabolites are electrophiles that cause cell injury by forming covalent bonds with nucleophilic targets on biological macromolecules. Covalent reactions between nucleophilic and electrophilic reagents are however discriminatory, since there is a significant degree of selectivity associated with these interactions. Over the course of the past few decades, the theory of Hard and Soft, Acid and Bases (HSAB) has proven to be a useful tool in predicting the outcome of such reactions. This concept utilizes the inherent electronic characteristic of polarizability to define, for example, reacting electrophiles and nucleophiles as either hard or soft. These HSAB definitions have been successfully applied to chemical-induced toxicity in biological systems. Thus, according to this principle, a toxic electrophile reacts preferentially with biological targets of similar hardness or softness. The soft/hard classification of a xenobiotic electrophile has obvious utility in discerning plausible biological targets and molecular mechanisms of toxicity. The purpose of this Perspective is to discuss the HSAB theory of electrophiles and nucleophiles within a toxicological framework. In principle, covalent bond formation can be described by using the properties of their outermost or frontier orbitals. Because these orbital energies for most chemicals can be calculated using quantum mechanical models, it is possible to quantify the relative softness (σ) or hardness (η) of electrophiles or nucleophiles and to subsequently convert this information into useful indices of reactivity. This atomic level information can provide insight into the design of corroborative laboratory research and thereby help investigators discern corresponding molecular sites and mechanisms of toxicant action. The use of HSAB parameters has also been instrumental in the development and identification of potential nucleophilic cytoprotectants that can scavenge toxic electrophiles. Clearly, the difficult task of delineating molecular sites and mechanisms of toxicant action can be facilitated by the application of this quantitative approach.
Keywords: α,β-unsaturated carbonyl derivatives; acrolein; 4-hydroxy-2-nonenal; oxidative stress; neuroprotection; HSAB theory
INTRODUCTION
Unlike the formation of drug-receptor complexes that primarily involve short distance forces such as hydrogen-bonding, hydrophobic or van der Waals interactions, many chemical xenobiotics and/or their active metabolites are electrophiles (electron deficient) that form covalent bonds (e.g., SN2, Schiff base formation, Michael addition) with cognate nucleophilic (electron rich) sites on biological targets1–10. Cytotoxicity occurs because the formation of covalently bonded adducts can impair the functions of enzymes, DNA, cytoskeletal proteins and other macromolecules, thereby leading to defective cell processes. Thus, it is now recognized that electrophilic α,β-unsaturated carbonyl derivatives of the type-2 alkene chemical class (e.g., acrolein, acrylamide or methylvinyl ketone) cause broad organ system toxicity by forming covalent Michael-type adducts with nucleophilic sulfhydryl groups on functionally-critical proteins11–20. However, electrophiles do not react indiscriminately with nucleophiles and instead such interactions occur along a continuum of relative reactivity. The significant degree of selectivity that occurs in electrophile-nucleophile interactions is predicted by the Hard and Soft, Acid and Bases (HSAB) theory of Pearson5,17,21. Based on this concept, reactive molecules are assessed on the basis of their respective polarizability such that electrophiles and nucleophiles are classified as either soft (relatively polarizable) or hard (relatively non-polarizable). A useful theorem stemming from this principle is that toxic electrophiles react preferentially with biological targets of similar hardness or softness. Therefore, the α,β-unsaturated carbonyls can be viewed as soft electrophiles that cause cytotoxicity by selectively forming adducts with soft nucleophilic anionic thiolates on functionally critical proteins9,14–16,18.
Whereas the HSAB theory initially described hardness and softness in terms of the experimental ionization potential and electron affinity of the reacting molecules, these parameters also can be related (e.g., by Koopmans theorem) to the respective energies of the outermost or frontier molecular orbitals (FMOs). Since small molecule FMO energies can be determined computationally using various quantum mechanical models, HSAB parameters such as the softness (σ) or hardness (η) of an electrophile and its nucleophilic target can be readily derived. Correspondingly, the values for σ and η can be used in a more recently developed algorithm to calculate the electrophilic index (ω) of a toxicant, the value of which reflects the propensity of the electrophile to form adducts with a given biological nucleophile. Although more complex, the respective σ and η values for the nucleophile can also be used to derive an index of nucleophilicity (ω−, see ahead). On a pragmatic basis these parameters can be used to predict the toxic potential of electrophilic xenobiotic chemicals and to facilitate the identification of corresponding nucleophilic molecular sites of action5,8,17. Indeed, our research has shown that, excluding steric and other physiochemical issues (see ahead), the calculated values of these descriptors (σ, ω, ω−) directly corresponded to the second order rate constants for α,β-unsaturated carbonyl adduction of cysteine sulfhydryl groups. For individual members of a α,β-unsaturated carbonyl series, the kinetic and HSAB parameters were closely correlated to the respective magnitude of in vitro toxicity; i.e., disruption of synaptosomal function14–16,18. This ability of HSAB parameters (σ, η, ω, ω−) to predict the potency of a given chemical toxicant has significant implications for risk assessment19,20. In addition, these parameters are a useful tool in the search for macromolecular targets and subsequent elucidation of molecular mechanisms of toxicity. Therefore, in this Perspective, we will discuss the HSAB theory and define the physiochemical characteristics of hard and soft, electrophiles and nucleophiles. As we will point out, establishing structure-activity relationships (SAR) based on kinetic and HSAB properties can reveal the substructure (e.g., α,β-unsaturated aldehyde) or moiety (e.g., carbonyl group) responsible for the toxicity of electrophile. This forms a rational basis for categorizing a chemical series and for understanding the corresponding toxic mechanism19,22,23. Finally, in this Perspective we will present examples from the literature as a framework for demonstrating how quantum chemical calculations can be effectively applied toward understanding molecular toxicodynamic issues.
HSAB DEFINITIONS: SOFT AND HARD, ELECTROPHILES AND NUCLEOPHILES
Physiochemical Principles Determining the Selective Interactions of Electrophile and Nucleophile
HSAB theory classifies reacting species as either relatively “hard” or “soft”, based on polarizability; i.e., the ease with which electron density can be displaced or delocalized to form new covalent bonds. Polarizability is an inherent characteristic of electron distribution in atoms or molecules. Thus, electrons that are far from the influence of the nucleus or that occupy a large volume (electron “cloud”) are more likely to be displaced; i.e., redistributed into a new bonding pattern. For example, the conjugated α,β-unsaturated carbonyl structure of many type-2 alkenes is considered to be a soft electrophile (Table 1) because the delocalized pi electrons are mobile. This mobility can be considered the extension of an electron cloud over four nuclear centers (C=C-C=O) based on interactions between the orbitals of the electron-withdrawing carbonyl group and those of the alkene moiety. The extended cloud is easily distorted hence, “soft” (polarizable). In contrast, hard electrophilic toxicants, e.g., chloroethylene oxide or vinyl chloride (Table 1), have highly localized, non-extended charge densitites at specific electrophilic centers; e.g., the respective C1 carbon atoms. Consequently, these chemicals are characterized by low electron polarizability. The softness or hardness of a nucleophile is also determined by the polarizability of corresponding electrons. Sulfur has a large atomic radius so that its valence electrons are relatively far from the nucleus and, as such, are highly polarizable. Upon ionization of the thiol (i.e., SH → S−), the consequent expansion of the anionic cloud yields the relatively soft (most easily polarizable) thiolate nucleophile; e.g., compare the respective thiol- and thiolate-states of the amino acid residue, cysteine (Table 2). In contrast, nitrogen and oxygen nucleophiles have relatively small atomic radii and, accordingly, their electron clouds are less readily distorted. Consequently, such compounds are much harder nucleophiles; e.g., the methoxide ion and the primary nitrogen of the amino acid lysine (Table 2). Expansion of the electron cloud via nearby conjugation with unsaturated sites yields a less hard nucleophile; e.g., the secondary amine of histidine, the phenolate ion or the enolate of 2-acetylcyclopentanone (Table 2).
Table 1.
Hardness/Softness Values for Selected Electrophilea
| Compound | Structure | Hardness (η, ev) | Softness (σ, ev−1) | Comments |
|---|---|---|---|---|
| chloroethylene oxide |
|
4.26 | 0.235 | Produced tumors via DNA adducts |
| glycidamide |
|
3.72 | 0.269 | Metabolite of acrylamide- possible carcinogen |
| vinyl chloride |
|
3.55 | 0.282 | Carcinogenic, neurotoxic and hepatotoxic industrial chemical |
| 2,5-hexanedione |
|
3.23 | 0.310 | Metabolite of n- hexane- selective neurotoxicant |
| methyl crotonate |
|
3.05 | 0.328 | Industrial chemical |
| acrylamide |
|
2.89 | 0.346 | Selective neurotoxicant, suspected carcinogenic chemical |
| acrolein |
|
2.64 | 0.379 | Endogenous mediator of cellular oxidative stress |
| 4-hydroxy-2- nonenal |
|
2.55 | 0.393 | Endogenous mediator of cellular oxidative stress |
| t-butylquinone |
|
1.98 | 0.505 | Induces Antioxidant Response Element (ARE) |
Ground state equilibrium geometries were calculated for each structure with DF B3LYP-6-31G* in water from 6-31G* initial geometries. LUMO and HOMO energies were generated exclusively from corresponding s-cis conformations and were used to calculate η and σ (see text).
Table 2.
Hardness/Softness Values for Selected Nucleophilesa
| Compound | Structure | Hardness (η, ev) | Softness (σ, ev−1) | Comments |
|---|---|---|---|---|
| aminoguanadine |
|
3.73 | 0.268 | Putative cytoprotectant |
| cysteine thiol (0) | HSCH2CH(NH2)CO2H | 3.54 | 0.282 | Amino acid residue |
| lysine (0) | H2N(CH2)4CH(NH2)CO2H | 3.51 | 0.285 | Amino acid residue |
| methoxide ion | CH3O− | 3.47 | 0.288 | Organic nucleophile |
| histidine (sidechain) |
|
3.21 | 0.313 | Amino acid residue |
| 4-aminopyridine |
|
2.93 | 0.341 | Putative cytoprotectant |
| cysteine thiolate (−1) | −SCH2CH(NH2)CO2H | 2.61 | 0.382 | Amino acid residue |
| acetyl acetone anion |
|
2.52 | 0.398 | Putative cytorprotectant |
| phenolate ion |
|
2.51 | 0.399 | Organic nucleophile |
| acetylcyclopentanone anion (2-ACP) |
|
0.537 | 1.87 | Putative cytorprotectant |
Ground state equilibrium geometries were calculated for each structure with DF B3LYP-6-31G* in water from 6-31G* initial geometries. Values obtained were used to calculate σ and η (see text).
According to the selectivity principle of the HSAB model, soft electrophiles preferentially form adducts with nucleophiles of comparable softness, whereas hard electrophiles form adducts with hard nucleophiles (see ahead). The data presented in Table 2 indicate that, among the biological nucleophiles, the sulfhydryl thiolate state of cysteine residues is the softest5,8,17. Therefore, the preferred nucleophilic cellular targets of the soft electrophilic α,β-unsaturated carbonyls are cysteine sulfhydryl thiolate groups. In contrast, the neurotoxic n-hexane metabolite, 2, 5-hexanedione is a hard electrophile (Table 1) that preferentially forms adducts with harder nucleophiles such as nitrogen atoms on ε-amino group of lysine residues. Additional hard nucleophilic targets include the secondary imidazole nitrogen of histidine and the carbon, nitrogen and oxygen groups of DNA/RNA.
HSAB Descriptors of Electrophile-Nucleophile Adduct Formation
As indicated above, covalent bond formation between reacting molecules can be described by using the properties of their outermost orbitals. The two most important of these are the highest energy orbital that contains electrons (known by the acronym HOMO = Highest Occupied Molecular Orbital) and the lowest energy orbital that is vacant (LUMO = Lowest Unoccupied Molecular Orbital). Covalent bonding such as adduct formation occurs when electron density is transferred between the orbitals of the reacting species (nucleophile to electrophile) to form the new bonds of the product (the adduct). FMO energies (EHOMO, ELUMO) for a wide variety of chemical structures can be calculated from quantum mechanical models and the corresponding hardness (η) and softness (σ) can then be derived using equations (1) and (2).
| (1) |
| (2) |
In essence, softness measures the ease with which electron redistribution takes place during covalent bonding; i.e., nucleophile donation of electrons and acceptance by the electrophile. Therefore, with respect to electrophilic species, it is often the case that softness (higher σ value) is correlated with ease of adduct formation (expressed, for example, as a reaction rate). The electrophilic index (ω) is a parameter that combines softness and chemical potential (μ; equation 3)24. The latter parameter, μ, is the propensity of a species to undergo chemical change. Thus, ω is calculated according to equation (4) and represents a more comprehensive measure of electrophilic reactivity.
| (3) |
| (4) |
With respect to the nucleophile, the corresponding molecular orbital energies can also be used to calculate nucleophilic softness and chemical potential as shown above in equations (2) and (3). In addition, the likelihood that a given nucleophile (A) will form an adduct with a given electrophile (B) can be predicted by calculating a nucleophilicity index (ω−) using equation (5)25.
| (5) |
This parameter considers the hardness (η) and chemical potential (μ) of both the electrophilic and nucleophilic reactants. The electrophilic (ω) and nucleophilic (ω−) indices have been demonstrated to be reliable descriptors for a variety of electrophile-nucleophile interactions8,18,27–28.
To perform the quantum mechanical computations numerous computer software packages such as Gaussian (http://www.gaussian.com), HyperChem (www.hyper.com), Q-Chem (http://www.q-chem.com), Spartan (www.wavefun.com), etc., are available commercially. In addition, there are many open source programs like GAMESS (www.msg.chem.iastate.edu/gamess), deMon (www.demon-software.com/public_html/index) and Abinit (www.abinit.org) among others that could presumably be used to make these types of calculations. While various models exist, density functional theory (DFT) provides the most consistently employed approach (the B3LYP model) for the purposes described by this review. However, in one case (see ahead) we used a Hartree-Fock (HF) model with good results. Although in most of the work described here molecular geometries (or energies) are calculated in water, we have also reported an application using gas phase (in vacuum) calculations. The use of either state can be rationalized but, in our applications, no differences in the results were observed as long as the method chosen was consistently employed. Throughout this study only global (i.e., whole molecule) parameters are considered but the use of localized functions at sites of reactivity within a molecule has been successfully applied by others in the development of computational models23,24.
TOXICOLOGICAL APPLICATION OF HSAB PRINCIPLES
Whereas exceptions exist, most toxic chemicals are electrophiles that produce toxicity by interacting with biological nucleophiles5,6,8,10,29 and, therefore, the HSAB concepts should have broad applicability to the field of Molecular Toxicology. In the following sections we will demonstrate how the application of HSAB principles can help identify the sites and mechanisms of toxicant action. Thus, we will consider the application of HSAB principles to recent structure-toxicity studies involving acrolein, 4-hydroxy-2-nonenal and other α,β-unsaturated carbonyl and aldehyde derivatives. In addition, we will discuss the role of HSAB principles in the development of nucleophilic 1,3-dicarbonyl compounds that might be useful in treating disease processes involving endogenous α,β-unsaturated carbonyl compounds. Although the HSAB calculations are broadly applicable and straightforward, our discussions of these studies will also serve to identify certain physiochemical toxicant characteristics and intervening biological factors that can influence toxic expression and interpretation of the quantum mechanical data.
α,β-Unsaturated Carbonyl Derivatives: Toxicological Consequences of Exposure
Acrylamide (ACR), acrolein, 4-hydroxy-2-nonenal (HNE) and other structurally related derivatives (Table 1) are characterized by a conjugated α,β-unsaturated carbonyl substructure that is formed when an electron-withdrawing group (e.g., a carbonyl group) is linked to an alkene. These are therefore soft electrophiles of the type-2 alkene chemical class. Members of this class are used extensively in the manufacturing, agricultural and polymer industries and, consequently, occupational human exposure is significant. In addition, these chemicals are recognized as environmental pollutants and dietary contaminants; e.g., acrolein from combustion of petrochemical fuels, methyl vinyl ketone (MVK) in automobile exhaust, and ACR in French fries. α,β-Unsaturated carbonyl derivatives are also prevalent components of cigarette smoke; e.g., acrolein, ACR and acrylonitrile. Acute or chronic exposure to these type-2 alkenes has been linked to major organ system toxicity and to possible carcinogenicity in humans and laboratory animals5,30–34. In addition to environmental or exogenous intoxication, acrolein, HNE and certain other α,β-unsaturated aldehydes are highly toxic by-products of membrane lipid peroxidation associated with cellular oxidative stress. Growing evidence indicates that these endogenous type-2 alkenes play a pathogenic role in many diseases that have oxidative stress as a common molecular etiology; e.g., atherosclerosis, Alzheimer’s disease, diabetes5,13,17,35,36. Clearly, the type-2 alkenes are an important class of chemicals with respect to environmentally acquired toxicity and endogenous disease pathogenesis. As described in the following subsection, deciphering the mechanism of type-2 alkene cytotoxicity can be aided significantly by application of HSAB concepts and quantum mechanical descriptors.
α,β-Unsaturated Carbonyl Derivatives: Softness and Electrophilicity
As discussed above, the relative softness and electrophilicity of a α,β-unsaturated carbonyl derivative can be calculated using LUMO and HOMO energies determined via quantum mechanical models. As the data in Table 3 illustrate, acrolein and HNE are the strongest electrophiles among the type-2 alkenes tested; i.e., the respective gas phase electrophilicity index (ω) is numerically larger than other constituents in the chemical series. In contrast, acrylamide (ACR) and methyl acrylate (MA) are substantially weaker electrophiles, whereas MVK exhibits intermediate electrophilic reactivity. Overall, the type-2 alkene electrophilic indices suggest the following rank order of electrophilicity: acrolein ≈ HNE > MVK ≫ MA ≥ ACR. In this type-2 alkene series, the relative differences in electrophilicity are determined by substituent functional groups and their respective contributions to the electron density of the α,β-unsaturated carbonyl structure. Allyl alcohol and propanal do not contain extended pi electron systems and therefore, have substantially lower values of electrophilicity compared to acrolein and related conjugated analogs (Table 3). Since allyl alcohol and propanal lack a conjugated structure, neither of these substances can undergo Michael-type reactions; i.e., conjugate addition of a nucleophile. Subsequent experimental research showed that softness and electrophilicity were determinants of the chemical reactions that mediate type-2 alkene toxicity14–16. Excluding HNE (see below), the rank order of electrophilicity was closely correlated (r2 > 0.90) to the corresponding second order rate constants for the adduct reaction with cysteine (log k2) and to the respective potencies (log IC50) for in vitro nerve terminal (synaptosomes) toxicity (Table 3). While this correlated data set consists of only four compounds, it should be recognized that each structure represents a different functional group (i.e., aldehyde, ketone, ester and amide) and thus, constitutes a significant range of potential variability. Within the confines of a particular functional group (e.g., esters), electrophilicity is consistently expressed (see Table 5). Molecular softness was also correlated to these experimental parameters but to a slightly lesser extent (r2 ≈ 0.80). These data suggest that electrophilicity governs the cysteine adduction rate and toxicity of a chemical and that softness also is an important factor.
Table 3.
Calculated and Experimental Parameters for Conjugated Type-2 Alkenes and Non-Conjugated Analogs
| Type-2 alkene | a ELUMO (ev) | EHOMO (ev) | σ (×10−3 ev−1) | ω (ev) | b Log k2 (pH=7.4) | c Uptake Inhibition (log IC50) |
|---|---|---|---|---|---|---|
| Acrolein | −1.70 | −6.98 | 379 | 3.57 | 2.596 | −4.28 |
| MVK | −1.46 | −6.69 | 382 | 3.18 | 2.048 | −3.48 |
| HNE | −1.84 | −6.93 | 393 | 3.78 | 0.938 | −3.40 |
| MA | −1.01 | −7.36 | 315 | 2.76 | −1.893 | −0.34 |
| ACR | −1.00 | −6.78 | 346 | 2.62 | −1.804 | −0.36 |
| Nonconjugated analogs | ||||||
| d Propanal | −0.65 | −6.84 | 323 | 2.26 | - | - |
| d Allyl alcohol | +0.18 | −7.06 | 276 | 1.63 | - | - |
ELUMO and EHOMO were obtained after calculating ground state equilibrium geometries for each compound with DF B3LYP-6-31G* in vacuum from 6-31G* initial geometries. These values were generated exclusively from corresponding s-cis conformations and were used to calculate softness (σ) and the electrophilic index (ω) of each electrophile as described in LoPachin et al.15.
Second-order reaction rates (k2) were determined for type-2 alkene reactions with L-cysteine at pH 7.4 (n=4–6 experiments).
Inhibition of synaptosomal membrane 3H-DA uptake was determined in striatal synaptosomes exposed to type-2 alkenes (n=4–6 experiments)14.
Does not undergo the Michael Reaction.
Table 5.
Acrylate and Methacrylate Oral Lethality in Mice
| Ester | LD50a (mmol/kg) | Log Pa | Log ka | ω (ev)b |
|---|---|---|---|---|
| methyl acrylate | 9.6 | 0.8 | 1.602 | 3.2245 |
| ethyl acrylate | 17.97 | 1.33 | 1.428 | 3.1981 |
| n-butyl acrylate | 58.98 | 2.36 | 1.401 | 3.196067 |
| isobutyl acrylate | 47.63 | 2.22 | 1.431 | 3.196067 |
| 2-hydroxyethyl acrylate | 5.177 | −0.21 | 1.919 | 3.20026 |
| 2-hydroxypropyl acrylate | 8.112 | 0.35 | 1.758 | 3.214 |
| methyl methacrylate | 51.97 | 1.38 | −0.675 | 2.9967 |
| ethyl methacrylate | 68.64 | 1.94 | −0.403 | 2.9729 |
| isopropyl methacrylate | 67.84 | 2.25 | −0.876 | 2.9708 |
| n-butyl methacrylate | 142.7 | 2.88 | −0.655 | 2.95895 |
| isobutyl methacrylate | 83.14 | 2.66 | −0.769 | 2.9708 |
| 2-hydroxyethyl methacrylate | 45.24 | 0.47 | −0.273 | 3.0108 |
| 2-hydroxypropyl methacrylate | 55.24 | 0.97 | −0.273 | 2.9848 |
| tert-butyl methacrylate | 60.12 | 2.54 | −0.632 | 2.9708 |
Data from Tanii and Hashimoto42.
ω = μ2/2η (see text). Orbital energies were generated exclusively from corresponding s-cis conformations and were obtained from ground state equilibrium geometries computed using DF B3LYP 6-31G* in water starting from 6-31G* geometry.
α,β-Unsaturated Carbonyl Electrophilicity: Intervening Variables That Influence Interpretation
The preceding data indicate that, although values for HNE electrophilicity and softness were higher than those of acrolein and MVK37, the rank order of the respective adduct rate constant (log k2) and toxic potency (log IC50) were substantially lower than predicted by the HSAB parameters. This discrepancy would seem to indicate a limited role for electrophilicity in determining toxic expression. However, the extended alkane tail of HNE (Tables 1 and 4) imposes significant steric hindrance that can impede access to the active site of many enzymes and thereby slow the corresponding kinetics of adduct formation and reduce toxic potency37. Such disagreement between direct chemical measurements and calculated HSAB parameters should be expected, since the respective algorithms for σ and ω do not consider steric factors. As an additional illustration of steric influences, Seiner et al.38 demonstrated that acrolein and a series of structurally related aldehydes inhibited protein tyrosine phosphatase 1B (PTP1B) activity via covalent modification of a specific cysteine residue (Cys215). The order of potency was: acrolein ≫ crotonaldehyde > 3-methyl-2-butanal ≈ propanal. When the corresponding aqueous phase electrophilic indices (ω) were calculated retrospectively, the greater ability of acrolein to inactivate PTP1B was clearly related to correspondingly higher electrophilicity (ω = 3.82ev), whereas the reduced potency of crotonaldehyde was a function of lower electrophilicity (ω = 3.27ev). However, the ω value for 3-methyl-2-butanal (ω = 3.31) was significantly higher than that of propanal (ω = 2.32) and equivalent to that of crotonaldehyde (ω = 3.27). Similar to the previous HNE study (Table 4), this order of electrophilicity is not consistent with the rank order of potency. Nonetheless, as the authors indicate, it can be rationalized by steric hindrance imposed through the bulky tertiary alkene terminus of 3-methyl-2-butanal. It is noteworthy that, due to its significant ω value, this compound would likely inactivate PTP1B at higher concentrations and/or longer exposure times that overcome steric hindrance. However, this is not the case for propanal, since it is neither structurally nor electronically capable of irreversible sulfhydryl adduction.
Table 4.
Reaction of HNE/ONE analogues with N-acetylcysteine
| Structure | Namea | k (M−1s−1)a,b | t1/2 (s) a,b | ω (ev) c | ω (ev) d |
|---|---|---|---|---|---|
|
ONE | 238 | 7.1 | 1.7354 | 5.4716 |
|
|
ONE-CO2Me | 301 | 7.1 | 1.7354 | 5.4729 |
|
|
ONE-CO2H | 169 | 13.9 | 1.7354 | 5.4495 |
|
|
ONE-CO2− | 169 | 13.9 | 1.6613 | --e |
|
ONEA | 1.72 | 580 | 1.7017 | 4.9213 |
|
ONEA− | 1.72 | 580 | 1.3430 | 3.6997 |
|
HNE | 1.22 | 732 | 1.1819 | 3.8038 |
|
|
HNE-CO2Me | 1.18 | 794 | 1.1798 | 3.8038 |
|
|
HNE-CO2H | 0.79 | 1213 | 1.1798 | 3.7882 |
|
|
HNE-CO2− | 0.79 | 1213 | 1.1535 | 3.6105 |
|
HNEA | NR | NR | 1.2272 | 3.2497 |
|
HNEA− | NR | NR | 0.7367 | 1.8417 |
Data are from McGrath et al.39 and shaded entries indicate dominant species (see corresponding text).
Half-lives and rate constants from reaction with N-acetylcysteine at pH 7.4, 37C.
ω = μ2/2η (see text). Orbital energies were generated exclusively from corresponding s-cis conformations and using ground state equilibrium geometries computed using HF 6-31G* in water starting from 3-21G geometry.
Orbital energies were generated exclusively from corresponding s-cis conformations and were obtained from ground state equilibrium geometries computed using DF B3LYP 6-31G* in water starting from 6-31G* geometry.
Failed to converge.
As part of a structure-toxicity analysis of lipid electrophiles generated in vivo during phospholipid peroxidation, McGrath et al.39 determined the corresponding half-lives (t1/2) and second order rate constants (k2) for the reactions of HNE, 4-oxonenal (ONE) and analogue metabolites (Table 4) with N-acetylcysteine (NAC). As indicated above these lipid derivatives are α,β-unsaturated carbonyl compounds that mediate cytotoxicity through irreversible modification of macromolecules and disruption of cellular response pathways17,40,41. When the corresponding electrophilicity values (ω) for the HNE analogues were calculated, the kinetic parameters (t1/2, k2) were only qualitatively correlated to ω unless the acidity of certain metabolites (RCOOH → RCOO−) was considered. Specifically, when structures of the dominant anionic species (RCOO−) at pH 7.4 were used in a HF quantum mechanical model, correlation of both k2 and t1/2 with ω improved from r2 = 0.553 to 0.906 and r2 = 0.752 to 0.911, respectively. In addition, the lack of reactivity exhibited by HNEA in this study can be related to the extremely low value of ω calculated for its conjugate base (Table 4). It can also be seen from Table 4 that although the DF model yielded numerically different values for ω, the same result was obtained; i.e., rate data were well correlated to electrophilicity when the relevant anionic species were considered.
Esters of acrylic acid and methacrylic acid are used extensively in the production of polymers for textiles, latex paints and medical/dental cements. The acrylates (CH2=CHCO2R) and methacrylates (CH2=CCH3CO2R) are conjugated α,β-unsaturated ester derivatives. Several lines of evidence suggest that these compounds produce toxicity (e.g., carcinogenicity, skin sensitization) through adduction of protein sulfhydryl groups20,42–44. Early studies by Tanii and Hashimoto42 determined the lethal oral doses (LD50) in mice for a broad spectrum of acrylates/methacrylates. Results indicated that the LD50 was related to both solubility (as a partition coefficient, log P) and the reaction rate (log k) of these esters with glutathione in a buffered physiological solution. When the electrophilic index (ω) was calculated for the 14 compounds (Table 5), we found that the corresponding rate constants (log k) were highly correlated (r2 = 0.97) to the ω parameter. In contrast, both log k (r2 = 0.65) and ω (r2 = 0.60) were only modestly correlated with the in vivo LD50 values. This discrepancy can, however, be explained by the variable solubility (log P; Table 5) of the acrylate and methacrylate compounds18 and by the fact that toxicant solubility is a physiochemical determinant of tissue distribution and, therefore, target accessibility. This is evidenced by comparing the respective data for the water soluble 2-hydroxyethyl acrylate (log P = −0.21) to the less soluble ethyl acrylate (P = 1.33); i.e., both have virtually identical ω values (~3.200 ev), but significantly different reaction rates (log k = 1.92 vs 1.43, respectively) and toxic potencies (LD50 = 5.2 mmol/kg vs. 18 mmol/kg, respectively). Clearly the chemical factors that establish solubility do not necessarily produce commensurate changes in electronic characteristics such as electrophilicity. This is not surprising since, although the hydroxyl group improves solubility (i.e., CH2=CHCO2CH2CH2OH vs CH2=CHCO2CH2CH3), this substituent is distant from the electrophilic site of the molecule (i.e., carbon-carbon double bond) and might have little effect on electrophilic reactivity. Thus, it should be evident from this example that, when individual differences in solubility are considered, the relative electrophilicity (ω) of the acrylates/methacrylates determines both the corresponding in vitro rate (log k) of cysteine adduct formation and the expression of in vivo toxicity18,29,44.
The preceding discussion indicates that a variety of chemical toxicants can be classified according to the quantitative HSAB descriptors of hardness (η) and softness (σ), as determined by quantum mechanical calculations. Furthermore, the degree of electrophilic reactivity (ω) for these compounds can also be quantitatively determined. This latter parameter is critically important since it is directly related the second order rate constant (k2) of the target adduct reaction and, therefore, reflects toxicological potential. Accordingly, ω has been suggested to be an in silico surrogate parameter for experimentally derived rate constants (k2) and, as such, might be a useful tool for predicting the toxicity of industrial chemicals10,19,20,22,44. The preceding discussion also pointed out that the HSAB algorithms do not account for possible intervening physiochemical variables; e.g., solubility, acid-base equilibrium and steric hindrance, that could independently modify toxicological outcome and lead to discrepancies in predicted vs. observed results. These issues have been addressed to some extent and, in at least one case, electrophilic and steric parameters were combined in a computational algorithm24.
The α,β-unsaturated ester and carbonyl derivatives discussed here form adducts with cysteine and other amino acid targets on proteins via second order (covalent) reactions. The rates of these reactions are not only dependent upon the toxicant ω, but also the nucleophilic status of the target residues. Therefore, in the next section, we will discuss the application of HSAB parameters to the identification of amino acid sites of toxicant action.
α,β-Unsaturated Carbonyl Derivatives: Nucleophilic Targets and Molecular Mechanisms of Toxicity
According to the selectivity principle of the HSAB theory, soft electrophiles should preferentially react with soft nucleophiles. There are several nucleophilic amino acid side chains that might be relevant protein targets for the α,β-unsaturated carbonyl compounds: i.e., sulfhydryl groups on cysteine (Cys) residues, the primary nitrogen atoms of the lysine (Lys) ε-amino group and the secondary nitrogen atoms of the imidazole group of histidine (His). Although the type-2 alkenes can form adducts with lysine and histidine residues40,45–52, the weight of kinetic and proteomic data indicate that cysteine sulfhydryl groups are the preferential targets for the type-2 alkenes11,12,14,16,37,40,41,49,52–58. On a quantitative basis, this cysteine preference is several orders of magnitude greater than that for the other biological nucleophiles. This differential is consistent with the fact that the side chain amino nitrogen groups of lysine and histidine are harder nucleophiles (Table 2) and have inherently lower reactivity for soft electrophiles such as the type-2 alkenes. The likelihood that a given nucleophile will form a covalent adduct with a type-2 alkene can be predicted by calculating an index of nucleophilicity (ω−, see above). This comprehensive parameter considers the hardness (η) and chemical potential (μ) of both the electrophilic (type-2 alkene) and nucleophilic (cysteine, histidine or lysine) reactants25. As suggested by the respective ω− values (Table 6), the type-2 alkenes preferentially form adducts with cysteine thiolate sites. However, based on a pKa of 8.3, the cysteine sulfhydryl sidechain is mostly protonated at physiological pH (7.4) and, therefore, exists primarily as the neutral (0) thiol. Also at this pH, the imidazole secondary amine of histidine (pKa of 6.0) is mostly deprotonated (0) and the primary ε-amino group amine of lysine (pKa = 10.5) is completely protonated (+1). As the corresponding HSAB parameters indicate (Table 2), the relative nucleophilicity values for the thiol and nitrogen sidechain groups are low and hence, these sidechain states are not particularly reactive. Instead, a large body of evidence indicates that the α,β-unsaturated carbonyls selectively form adducts with the highly nucleophilic thiolate of cysteine sulfhydryl groups. This anionic state can be found within specialized pKa-lowering microenvironments such as catalytic triads5,17 and, as the respective HSAB descriptors (Tables 2 and 6) demonstrate, cysteine thiolates are a much softer and significantly more reactive nucleophile than the Lys, His or thiol sulfhydryl groups.
Table 6.
Calculated Nucleophilic Indices (ω−) for Type-2 Alkene Reactions with Cysteine Sulfhydryl Groups
| Electrophile | aω− Cys (−1) | ω− Cys (0) | b log kRS− | c log IC50 |
|---|---|---|---|---|
| Acrolein | 2.03 | 0.103 | 3.417 | −4.28 |
| HNE | 1.93 | 0.083 | 1.759 | −3.40 |
| MVK | 1.83 | 0.064 | 2.953 | −3.48 |
| MA | 1.59 | 0.069 | 1.011 | −0.34 |
| ACR | 1.50 | 0.036 | 0.767 | −0.36 |
The nucleophilicity index (ω−) was calculated as ω− = ηA (μA − μB)2/2(ηA − ηB)2, where η = (ELUMO−EHOMO)/2, μ = (ELUMO+EHOMO)/2, A = reacting nucleophile and B = reacting electrophile15. FMO energies (ELUMO and EHOMO) were generated exclusively from corresponding s-cis conformations and were derived from equilibrium geometries of the electrophiles at the ground state calculated using DF B3LYP-6-31G* in water starting from 6-31G* geometries. For the sulfhydryl thiolate and thiol state, the respective ionization-states are presented in parentheses. The nucleophilicity index considers the respective hardness and chemical potential of the electrophilic (type-2 alkene) and nucleophilic (cysteine, histidine or lysine) reactants and is, therefore, a measure of the likelihood of subsequent adduct formation. As suggested by the respective ω−values, the type-2 alkenes preferentially form adducts with cysteine thiolate sites as opposed to the thiol state.
The k2 values at pH 7.4 were corrected for the corresponding cysteine thiolate concentration (kRS−) according to the algorithm: log (kRS− −k2) = log k2 + pKa − pH. Inhibition of membrane 3H-dopamine transport was determined in rat striatal synaptosomes exposed in vitro to graded concentrations of each type-2 alkene.
To provide experimental evidence for the thiolate-state preference of the α,β-unsaturated carbonyls, we determined the effects of pH on the corresponding rates of adduct formation. The thiolate concentration in solution will vary as a function of pH; i.e., given a cysteine pKa of 8.3, at physiological pH (7.4) the majority (~90%) of sulfhydryl groups will be in the non-reactive thiol-state, whereas at higher pH, the thiolate/thiol ratio will become increasingly larger. Thus, we found that the reactions of L-cysteine (pKa = 8.3) with selected type-2 alkenes were ten-fifteen times faster when the pH was increased from 7.4 to 8.814–16. The observed changes in second-order rate constant (k2) reflect the increased thiolate concentration at the higher pH value. The experimentally determined k2 can be used to derive an anionic rate constant (kRS−) as a quantifiable measure of the inherent (concentration independent) nucleophilic strength58. Using the expression log (kRS− − k2) = log k2 + pKa − pH (where kRS− represents the anionic rate constant), a representative series of thiolate rate constants were calculated. For each α,β-unsaturated carbonyl derivative, the corresponding thiolate rate constants (kRS−) were highly correlated to ω− (r2 = 0.91; Table 6). Furthermore, the fact that ω− and kRS− were closely correlated to the neurotoxic potencies (IC50’s; Table 3) provided evidence that thiolate targeting by acrolein and HNE has toxicological relevance15,16. Similarly, previously reported rate data (k2, kRS−) for the reactions of unhindered cysteine related thiolate nucleophiles58 with acrylonitrile were well correlated (r2 > 0.97) to our corresponding calculations of ω− values (Table 7).
Table 7.
Reaction of thiolate nucleophiles with acrylonitrile at pH 8.1 and 30°C
| Cysteine Analogue (pKa)a | Nucleophile | Log k2a | Log kb | ω− (ev)c |
|---|---|---|---|---|
| cysteine ethyl ester (6.53) |
|
−0.737 | −0.726 | 1.94 |
| cysteine (8.15) |
|
−0.668 | −0.341 | 2.16 |
| homocysteine (8.70) |
|
−0.921 | −0.223 | 1.93 |
| glutathione (8.56) |
|
−0.762 | −0.173 | 2.74 |
| N-acetylcysteine (9.52) |
|
−1.24 | 0.192 | 4.81 |
| 3-mercaptopropanoic acid (10.2) |
|
−1.57 | 0.535 | 6.91 |
| mercaptoacetic acid (10.05) |
|
−1.41 | 0.546 | 7.54 |
Data from Friedman et al.58
Calculated as log (k − k2) = log k2 + pKa − pH.
Orbital energies obtained from ground state equilibrium geometries computed using DF B3LYP 6-31G* in water starting from 6-31G* geometry.
As a more relevant experimental approach to defining the interactions of type-2 alkenes with cysteine sulfhydryl groups, we determined the effects of acrolein, MVK and ACR on erythrocyte glyceraldehyde-3-phosphate dehydrogenase (GAPDH) activity18. Consistent with the concepts of the previous section, the softness (σ) and electrophilicity (ω) values of the selected type-2 alkenes were related to the corresponding second order rate constants (log k2) and potencies (log KI) for GAPDH inhibition (Table 8). Whereas earlier proteomic studies demonstrated the cysteine preference of type-2 alkene adduct formation40,41,56,59,60, it is unlikely that these adducts all have toxicological relevance; i.e., the corresponding cysteine residues all play a vital role in protein function. Indeed, other studies indicated that the type-2 alkenes impaired protein function by reacting with specific cysteine residues on important cellular proteins; e.g., N-ethylmaleimide inhibits vesicle (H+)-ATPase activity by reacting with Cys25461; HNE adduct formation at Cys280 inhibits mitochondrial SIRT3 acitivity62. However, it was unclear why these residues were selectively targeted. Therefore, we used tandem mass spectrometry to quantify the adduct formation associated with graded concentrations of a weak electrophile, ACR18. Results indicated that lower in vitro concentrations of ACR inhibited GAPDH activity by selectively forming adducts with Cys 152 in the active site of this enzyme, whereas at higher concentrations, ACR also reacted with Cys 156 and Cys247. Calculations using the PROPKA program revealed a pKa of 6.03 for Cys152, whereas the pKa values for Cys156 and Cys247 were higher. Furthermore, we found that GAPDH inhibition by the selected type-2 alkenes was pH-dependent indicating thiolate mediation. These data suggest that Cys152 is contained within a low pKa microenvironment63,64 and that ACR reacted preferentially with the resulting sulfhydryl thiolate.
Table 8.
HSAB and Kinetic Parameters for Type-2 Alkene Interactions with GAPDH.
| a Electrophile | σ (× 10−3 ev−1) | ω (ev) | log k2 | log KI |
|---|---|---|---|---|
| b Acrolein | 371 | 3.82 | 4.250 | −4.419 |
| MVK | 363 | 3.38 | 3.885 | −4.220 |
| ACR | 315 | 2.61 | 0.502 | −0.607 |
HSAB (σ, ω) and kinetic parameters (k2, KI) were calculated as described in Martyniuk et al.18.
Based on the HSAB parameters, acrolein and MVK are significantly softer and more reactive electrophiles than ACR; i.e., larger values of σ and ω, respectively. The rank orders of respective σ and ω values for each type-2 alkene were closely correlated to the corresponding rate constants (k2; r2 = 0.9996 and 0.9359, respectively) and relative potencies (KI; r2 = 0.9926 and 0.9004, respectively) for inhibition of GAPDH activity.
Considered together, our data indicate that α,β-unsaturated carbonyl chemicals produce cytotoxicity by forming Michael-type adducts with sulfhydryl groups on specific cysteine residues5,17,59. The elucidation of this mechanism was guided by HSAB-based calculations of softness and hardness, which indicated that the type-2 alkenes were electrophiles of varying softness and that, as such, these chemicals could form covalent bonds (adducts) with nucleophiles of comparable softness. Calculation of ω− suggested nucleophilic anionic thiolates as potential molecular sites of electrophile action. Cysteine thiolates are present in the active sites of many proteins where they play critical roles in modulating protein activities and, therefore, post translational modification via adduct formation would cause cytotoxicity by inhibiting the function of important proteins; e.g., N-ethylmaleimide sensitive factor (NSF), GAPDH, ubiquitin carboxyl terminal hydrolase-L1 (UCH-L1), clathrin and vesicular-ATPase11–14. These predictions were corroborated by direct evidence from a variety of proteomic and kinetic experimental approaches in both in vitro and in vivo models of type-2 alkene toxicity5,17,31,59. Because these thiolate targets are acceptors for nitric oxide (NO) and other modulatory electrophiles, we have proposed that toxicity induced by α,β-unsaturated carbonyl exposure is mediated by disruption of cellular redox signaling pathways5,17,31,65. As will be discussed, a similar approach was used to decipher the mechanism of protection against cellular oxidative stress provided by 1,3-dicarbonyl enols.
α,β-Unsaturated Carbonyl Derivatives: Relevance of HSAB Calculations to In Vivo Toxicokinetics and Toxicodynamics
The evidence reviewed above indicates that the type-2 alkenes cause cytotoxicity through a common molecular mechanism. This common mode of action suggests that members of this chemical family should, depending upon route of exposure, produce a similar pattern of organ system toxicity. However, ACR intoxication in laboratory animals or humans (e.g., occupational exposure or poisoning) produces selective neurotoxicity, whereas similar intoxication with acrolein, MVK or other type-2 alkenes causes peripheral organ toxicity5,31. This seemingly inconsistent diversity in toxicological responses is not due to variations in mechanism, but to relative differences in electrophilicity that correspondingly influences tissue distribution and toxicokinetics. As we have discussed, acrolein is a highly reactive soft electrophile (Table 1) that rapidly form adducts with soft nucleophilic thiolate sites on cysteine residues of proteins (Table 6). Following systemic intoxication with a reactive type-2 alkene, the rapid formation of protein adducts essentially limits tissue distribution. Consequently, the resulting toxic manifestations are determined by the site of absorption; e.g., acrolein inhalation (cigarette smoke, pollution) produces pulmonary toxicity, whereas systemic acrolein intoxication is associated with hepatic and/or vascular toxicity66,67. In contrast to more reactive type-2 alkenes, ACR is a weak water-soluble electrophile (Table 1) that slowly forms adducts with protein thiolate sites (Table 6). Correspondingly, ACR is less influenced by systemic “adduct buffering” and therefore has a relatively large volume of distribution that includes the central nervous system68,69. In accordance with these concepts, oral acrolein intoxication of rats (0.05–0.5 mg/kg) produced centrolobular liver necrosis and vascular hypertension70, whereas oral ACR (10–50 mg/kg) caused selective neurotoxicity in this species71. However, the production of neurotoxicity is not simply a function of brain accessibility, since ACR has an equal propensity to form thiolate adducts in both nervous and non-nervous organ systems. Instead, our studies indicate that ACR neurotoxicity is mediated by selective nerve terminal damage and that several unique anatomical and functional characteristics predispose this neuronal region to electrophile-induced toxicity5,17. Specifically, as indicated above, we suspect that ACR (and other type-2 alkenes) causes cytotoxicity by reacting with thiolate sites that act as NO acceptors. Neurotransmission is a complex multistep processes that is highly regulated by NO signaling59 and, therefore, disruption of this pathway is likely to have a significant impact on presynaptic activity. Furthermore, the nerve terminal is anatomically separated from the cell body and is, as a result, devoid of transcriptional and translational abilities. Therefore, unlike the cell body, the nerve terminal is vulnerable to electrophile attack, since it cannot mount transcription-based cytoprotective mechanisms such as the Nrf2-Keap1 response72. Finally, relative to proteins in other nerve regions or cell types, the turnover of nerve terminal proteins is exceptionally slow73. Thus, when these proteins are rendered dysfunctional through cysteine adduct formation, they are replaced slowly. This leads to the accumulation of nerve terminal adducts11,12, progressive impairment of presynaptic processes13,57 and cumulative neurotoxicity71. Thus, although the type-2 alkenes have a common mechanism of cytotoxicity, differences in electrophilic strength among these chemicals can influence respective tissue distributions and therefore their toxicological manifestations.
THE CYTOPROTECTIVE PROPERTIES OF 1,3-DICARBONYL ENOLS: MECHANISTIC INSIGHTS GAINED BY HSAB QUANTUM MECHANICAL CALCULATIONS
Cellular Oxidative Stress: Phytopolyphenol Cytoprotection
There is general agreement that cellular oxidative stress is a common molecular etiology in many chronic disease states (e.g., Alzheimer’s disease, atherosclerosis) and acute injuries (e.g., stroke, traumatic spinal cord injury). A confluence of epidemiological data and clinical trials74,75, corroborated by laboratory evidence76–78, indicate that the course of these conditions can be significantly improved by the administration of plant-derived polyphenolic compounds such as curcumin (curry spice), resveratrol (red grapes) or phloretin (apple skins). It has been largely assumed that the protective effects of these phytopolyphenols were related to their abilities as antioxidants to trap reactive oxygen species. However, recent evidence indicates that polyphenolic cytoprotection involves scavenging of other electron-deficient species that also mediate oxidative stress; i.e., divalent metal ions (e.g., Fe2+, Cu2+) and toxic unsaturated aldehydes (e.g., acrolein, HNE)79–81. Structure-activity studies have indicated that the molecular determinant of these protective actions is resident enol moieties82–84. For example, the α-carbon hydrogen atoms on the central β-diketone bridge of curcumin are acidic and, upon ionization, in physiological buffers, a carbanionic enolate is formed as the corresponding conjugate base. Moreover, the characteristic phenols of flavonoids such as phloretin are enols, since they consist of a hydroxyl group attached to a carbon-carbon double bond. These enols will also form nucleophilic enolate ions. Despite therapeutic potential, however, the clinical utility of the phytopolyphenols could be limited by poor bioavailability, toxicity and chemical instability36,85,86.
1,3-Dicarbonyl Enols: A New Class of Cytoprotectants
The search for safe, water-soluble phytopolyphenol analogs led to the discovery that 1,3-dicarbonyl enols such as 2-acetylcyclopentanone (2-ACP) and acetylacetone (AcAc; Table 2) might be cytoprotective87. The structure of these simple soluble enols resembles the central diketone–bridge of curcumin. Like the phytopolyphenols, the α-carbon hydrogen atoms of these simple enols can also readily ionize to form highly nucleophilic soft enolates. Indeed, our studies87 showed that the 1,3-dicarbonyl compounds provided levels of cytoprotection in several in vitro models of oxidative stress that exceeded those of the phytopolyphenols. The evidence suggested at least two mechanisms of 1,3-dicarbonyl cytoprotection in oxidative stress-induced cell injury. First, metal ion chelation mediated by bidentate coordination through the β-diketone structure. Presumably, the resulting inhibition or modification of the metal-catalyzed Fenton reaction reduces the cellular free radical burden. Second, the nucleophilic β-dicarbonyl enolates act as soft surrogate targets for free acrolein and other electrophilic α,β-unsaturated aldehydes. The reduction in toxic aldehyde content prevents secondary protein dysfunction in exposed cells. In studies that specifically examined the latter cytoprotective component, we identified the following rank order of 1,3-dicarbonyl analogs with respect to protection in acrolein-exposed neuronal cell culture systems: 2-ACP>AcAc, 1,1,1-tri-fluoro-2,4-pentanedione (TFPD)≫diethylmalonate (DEM). This sequence reflects the differences in second order rate constants (k2) for the reaction of these 1,3-dicarbonyls with acrolein. The differential reactivity of the 1,3-dicarbonyls can be explained by the acidity (pKa) of the parent compound and by the inherent nucleophilicity of the corresponding enolate. The pKa values indicate the relative extent of ionization (enolate formation) and hence, reflect nucleophilic concentration as a factor contributing to reaction rate.
1,3-Dicarbonyl enols: HSAB Parameters
As discussed previously, the nucleophilic strength of an enolate carbanion can be quantified by ω−5,17. The ω− values computed for reactions between acrolein and various nucleophiles are presented in Table 9. A nucleophile of significant reactivity (high ω− value) will increase the reaction rate (k2) with a given electrophile by lowering the energy of the transition state. Therefore, ω− values should correlate with the relative rate at which a given concentration of enolate reacts with a specific type-2 alkene (Table 9). Inherent differences in the respective ω− and known pKa values provide a molecular explanation of the corresponding adduct reaction rates and, hence, cytoprotective potency. Thus, 2-ACP is reasonably acidic (30–40% ionized at pH = 7.4; pKa = 7.8) and forms an enolate that is a powerful nucleophile (relative ω− = 401). Correspondingly, it exhibited superior protective capacity in all toxicity models. In contrast, AcAc is less reactive toward electrophiles, not only because it ionizes to a lesser extent (2% at pH 7.4; pKa = 8.9), but also because it is a weaker nucleophile (ω− = 160). Although TFPD is highly acidic (pKa= 4.7), the resulting higher concentration of enolate at physiological pH is offset by its weakness as a nucleophile (ω − = 108). Conversely, the enolate form of DEM is a significant nucleophile (ω − = 228). However, the low acidity (pKa = 12.9) of this chemical precludes any potential capability as a protectant, since less than 0.001% would be in the enolate state at physiological pH. NAC (pKa = 9.5) ionizes poorly in biological solutions, but is protective against acrolein-induced thiol loss and toxicity because the nucleophilicity of the thiolate anion is relatively high (ω− = 316). Phloretin has several enolizable sites and, although the nucleophilicity of these sites is modest (e.g., the relative ω− of the C-3 enol on the A ring = 139), the corresponding pKa value of 7.3 indicates significant (> 50%) ionization. Therefore, at physiological pH the high concentration of enolate and multiple site potential enable phloretin to provide significant thiol preservation through acrolein adduction. Together, these results indicate that the ability of 1,3-dicarbonyl compounds to act as acrolein targets is a predictable function of enolate formation and the inherent nucleophilicity of these carbanions. We are currently using the ability to quantify nucleophilicity (ω−), in conjunction with a high level of chemical understanding (i.e., conformational flexibility, pKa and nucleophilicity requirements) derived from extensive experimentation, to design and identify efficacious cytoprotective 1, 3-dicarbonyl analogs.
Table 9.
HSAB and Kinetic Parameters for Reactions of 1,3-Dicarbonyl Compounds with Acrolein.
| Compound | aω− (×10−3 ev) | pKa | b k2 rate constant |
|---|---|---|---|
| 2-ACP | 401 | 7.8 | 0 |
| AcAc | 160 | 8.9 | −24.9 |
| TFPD | 108 | 4.7 | −52.1 |
| DEM | 228 | 12.9 | −78.7 |
| Phloretin | 139 | 7.3 | −1.9 |
| NAC (−2) | 316 | 9.5 | nd |
The nucleophilic index (ω−) was calculated based on the reaction of acrolein with the selected 1,3-dicarbonyl and was calculated according to the algorithm provided in the text. FMO energies were generated exclusively from corresponding s-cis conformations and were calculated as equilibrium geometries at the ground state using DF B3LYP-6-31G* in water starting from 6-31G* geometries.
Second order rate constants (k2) for the reactions of 1,3-dicarbonyls with acrolein are derived from LoPachin et al.87 and are expressed as nM sulfhydryl loss s−1.
SUMMARY
In the field of Toxicology, the irreversible covalent interaction of a toxic electrophile and its cognate nucleophilic target is recognized as a basic reaction mediating chemical-induced cell injury. It is now understood that electrophile-nucleophile reactions exhibit a significant degree of selectivity, in that a given electrophile preferentially reacts with specific nucleophiles of comparable softness or hardness. This selectivity is based on electronic and structural characteristics that constitute the soft and hard classifications of the HSAB theory. In this Perspective, we have shown that the soft-soft interactions of electrophilic α,β-unsaturated carbonyl and aldehyde derivatives with their nucleophilic sulfhydryl thiolate targets can be understood and predicted through the calculation of HSAB parameters. Hard-hard interactions can also be quantitatively described and used to clarify toxicodynamics. Accordingly, we have employed HSAB calculations to describe the interactions of 2,5-hexanedione, the hard electrophilic metabolite of the parent compound, n-hexane, with possible hard nucleophilic targets in nervous tissue; e.g., ε-amino groups on lysine residues of axon cytoskeletal proteins88. Similar to the n-hexane/2,5-hexanedione relationship, many toxicants are metabolic derivatives of a less reactive parent or protoxicant; e.g., desulfuration of the relatively soft electrophilic chlorpyrifos parent to the highly reactive hard electrophilic oxon metabolite (chlorpyrifos oxon). Therefore, on a theoretical basis, HSAB calculations could also be used to determine the electrophilic reactivity and potential toxicity of metabolites derived from less reactive protoxicants. However, despite these obvious beneficial applications of the HSAB calculations, in vivo and in vitro model systems and their presumed macromolecular targets are highly complex and, accordingly, accurate formulation of kinetic or mechanistic predictions is dependent upon knowledge of additional chemical features, such as steric hindrance, that might independently influence adduct reaction rates. Furthermore, it should be recognized that the relative electrophilicity of a toxicant will influence corresponding in vivo toxicokinetics and the organ systems affected, as evidenced in our study of type-2 alkene toxicity. Regardless, HSAB calculations provide molecular level information that can offer guidance for corroborative laboratory research and thereby help investigators discern corresponding electrophile molecular mechanisms and sites of toxicant action. The use of quantum chemical calculations has also been instrumental in the development and identification of potential nucleophilic “antagonists”, which can scavenge electron-deficient species that mediate many diseases with a common etiology of cellular oxidative stress. Clearly, the difficult task of delineating molecular sites and mechanisms of toxicant action can be advanced by the application of quantum mechanical approaches.
Acknowledgments
FUNDING SUPPORT. Research discussed in this manuscript was supported by NIH grants from the National Institutes of Environmental Health Sciences to R.M.L. (NIEHS RO1 ES03830-24; NIEHS RO1 07912-13).
Abbreviations
- HSAB
hard and soft, acids and bases
- FMOs
frontier molecular orbitals
- SAR
Stucture-Activity Relationship
- LUMO
lowest unoccupied molecular orbital
- HOMO
highest occupied molecular orbital
- DFT
density-functional theory
- HTT
Hartree-Fock theory
- ACR
acrylamide
- HNE
4-hydroxy-2-nonenal
- MVK
methylvinyl ketone
- MA
methyl acrylate
- PTP1B
protein tyrosine phosphate 1B
- NAC
N-acetylcysteine
- LD50
lethal oral dose for 50% of the population
- GAPDH
glyceraldehydes 3-phosphate dehydrogenase
- SIRT3
mitochondrial sirtuin3
- NSF
N-ethylmaleimide sensitive factor
- UCH-L1
ubiquitin carboxyl terminal hydrolase-L1
- NO
nitric oxide
- Nrf2/Keap1
nuclear factor erythroid 2-related factor 2/kelch-like erythroid cell-derived protein with CNS homology-associated protein 1
- 2-ACP
2-acetylcyclopentanone
- AcAc
acetylacetone
- TFPD
1,1,1-tri-fluoro-2,4-pentanedione
- DEM
diethylmalonate
References
- 1.Cohen SD, Pumford NR, Khairallah EA, Boekelheide K, Pohl LR, Amouzadeh HR, Hinson JA. Selective protein covalent binding and target organ toxicity. Toxicol Appl Pharmacol. 1997;143:1–12. doi: 10.1006/taap.1996.8074. [DOI] [PubMed] [Google Scholar]
- 2.Coles B. Effects of modifying structure on electrophilic reactions with biological nucleophiles. Drug Met Rev. 1984–85;15:1307–1334. doi: 10.3109/03602538409029962. [DOI] [PubMed] [Google Scholar]
- 3.Hinson JA, Roberts DW. Role of covalent and noncovalent interactions in cell toxicity: effects on proteins. Ann Rev Pharmacol Toxicol. 1992;32:471–510. doi: 10.1146/annurev.pa.32.040192.002351. [DOI] [PubMed] [Google Scholar]
- 4.Liebler DC. Protein damage by reactive electrophiles: targets and consequences. Chem Res Toxicol. 2008;21:117–128. doi: 10.1021/tx700235t. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.LoPachin RM, Barber DS, Gavin T. Molecular mechanisms of the conjugated α,β-unsaturated carbonyl derivatives: relevance to neurotoxicity and neurodegenerative diseases. Tox Sci. 2008;104:235–249. doi: 10.1093/toxsci/kfm301. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.LoPachin RM, DeCaprio AP. Protein adduct formation as a molecular mechanism in neurotoxicity. Tox Sci. 2005;86:214–225. doi: 10.1093/toxsci/kfi197. [DOI] [PubMed] [Google Scholar]
- 7.Nelson SD, Pearson PG. Covalent and noncovalent interactions in acute lethal cell injury caused by chemicals. Annu Rev Pharmacol Toxicol. 1990;30:169–195. doi: 10.1146/annurev.pa.30.040190.001125. [DOI] [PubMed] [Google Scholar]
- 8.Schultz TW, Carlson RE, Cronin MTD, Hermens JLM, Johnson R, O’Brien PJ, Roberts DW, Siraki A, Wallace KB, Veith GD. A conceptual framework for predicting the toxicity of reactive chemicals: modeling soft electrophilicity. SAR QSAR Eviron Res. 2006;17:413–428. doi: 10.1080/10629360600884371. [DOI] [PubMed] [Google Scholar]
- 9.Schultz TW, Netzeva TI, Roberts DW, Cronin MTD. Structure-toxicity relationships for the effects to Tetrahymena pyriformis of aliphatic, carbonyl-containing α,β-unsaturated chemicals. Chem Res Toxicol. 2005;18:330–341. doi: 10.1021/tx049833j. [DOI] [PubMed] [Google Scholar]
- 10.Schwobel JAH, Koleva YK, Enoch SJ, Bajot F, Hewitt M, Madden JC, Roberts DW, Schultz TW, Cronin MTD. Measurement and estimation of electrophilic reactivity for predictive toxicology. Chem Rev. 2011;111:2562–2596. doi: 10.1021/cr100098n. [DOI] [PubMed] [Google Scholar]
- 11.Barber DS, LoPachin RM. Proteomic analysis of acrylamide-protein adduct formation in rat brain synaptosomes. Toxicol Appl Pharmacol. 2004;201:120–136. doi: 10.1016/j.taap.2004.05.008. [DOI] [PubMed] [Google Scholar]
- 12.Barber DS, Stevens S, LoPachin RM. Proteomic analysis of rat striatal synaptosomes during acrylamide intoxication at a low dose-rate. Toxicol Sci. 2007;100:156–167. doi: 10.1093/toxsci/kfm210. [DOI] [PubMed] [Google Scholar]
- 13.LoPachin RM, Schwarcz AI, Gaughan CL, Mansukhani S, Das S. In vivo and in vitro effects of acrylamide on synaptosomal neurotransmitter uptake and release. NeuroToxicology. 2004;25:349–363. doi: 10.1016/S0161-813X(03)00149-9. [DOI] [PubMed] [Google Scholar]
- 14.LoPachin RM, Barber DS, Geohagen BC, Gavin T, He D, Das S. Structure-toxicity analysis of Type-2 alkenes: in vitro neurotoxicity. Tox Sci. 2007;95:136–146. doi: 10.1093/toxsci/kfl127. [DOI] [PubMed] [Google Scholar]
- 15.LoPachin RM, Gavin T, Geohagen BC, Das S. Neurotoxic mechanisms of electrophilic type-2 alkenes: soft-soft interactions described by quantum mechanical parameters. Tox Sci. 2007;98:561–570. doi: 10.1093/toxsci/kfm127. [DOI] [PubMed] [Google Scholar]
- 16.LoPachin RM, Gavin T, Geohagen BC, Das S. Synaptosomal toxicity and nucleophilic targets of 4-hydroxy-2-nonenal. Tox Sci. 2009;107:171–181. doi: 10.1093/toxsci/kfn226. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.LoPachin RM, Gavin T, Petersen DR, Barber DS. Molecular mechanisms of 4-hydroxy-2-nonenal and acrolein toxicity: nucleophilic targets and adduct formation. Chem Res Toxicol. 2009;22:1499–1508. doi: 10.1021/tx900147g. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Martyniuk CJ, Fang B, Koomen JM, Gavin T, LoPachin RM, Barber DS. Molecular mechanisms of α,β-unsaturated carbonyl toxicity: cysteine-adduct formation correlates with loss of enzyme function. Chem Res Toxicol. 2011 doi: 10.1021/tx200437y. submitted. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Enoch SJ, Cronin MTD, Schultz TW, Madden JC. Quantitative and Mechanistic Read Across for Predicting the Skin Sensitization Potential of Alkenes Acting via Michael addition. Chem Res Toxicol. 2008;21:513–520. doi: 10.1021/tx700322g. [DOI] [PubMed] [Google Scholar]
- 20.Schwobel JAH, Wondrousch D, Koleva YK, Madden JC, Cronin MTD, Schuurmann G. Prediction of Michael-Type Acceptor Reactivity toward Glutathione. Chem Res Toxicol. 2010;23:1576–1585. doi: 10.1021/tx100172x. [DOI] [PubMed] [Google Scholar]
- 21.Pearson RG. Hard and soft acids and bases – the evolution of a chemical concept. Coord Chem Rev. 1990;100:403–425. [Google Scholar]
- 22.Wondrousch D, Bohme A, Thaens D, Ost N, Schuurmann G. Local electrophilicity predicts the toxicity-relevant reactivity of Michael acceptors. J Phys Chem Lett. 2010;1:1605–1610. [Google Scholar]
- 23.Koleva YK, Madden JC, Cronin MTD. Formation of categories from structure-activity relationships to allow read-across for risk assessment: toxicity of α,β-unsaturated carbonyl compounds. Chem Res Toxicol. 2008;21:2300–2312. doi: 10.1021/tx8002438. [DOI] [PubMed] [Google Scholar]
- 24.Chattaraj PK, Sarkar U, Roy DR. Electrophilicity index. Chem Rev. 2006;106:2065–2091. doi: 10.1021/cr040109f. [DOI] [PubMed] [Google Scholar]
- 25.Jaramillo P, Periz P, Contreras R, Tiznada W, Fuentealba P. Definition of a nucleophilicity scale. J Phys Chem A. 2006;110:8181–8187. doi: 10.1021/jp057351q. [DOI] [PubMed] [Google Scholar]
- 26.Cronin MTD, Manga N, Seward JR, Sinks GD, Schultz TW. Parametrization of electrophilicity for the prediction of the toxicity of aromatic compounds. Chem Res Toxicol. 2001;14:1498–1505. doi: 10.1021/tx015502k. [DOI] [PubMed] [Google Scholar]
- 27.Geiss KT, Frazier JM. QSAR modeling of oxidative stress in vitro following hepatocyte exposures to halogenated methanes. Toxicol In Vitro. 2001;15:557–563. doi: 10.1016/s0887-2333(01)00063-7. [DOI] [PubMed] [Google Scholar]
- 28.Maynard AT, Huang M, Rice WG, Covell DG. Reactivity of the HIV-1 nucleocapsid protein p7 zinc finger domains from the perspective of density-functional theory. Proc Natl Acad Sci. 1998;95:11578–11583. doi: 10.1073/pnas.95.20.11578. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Aptula AO, Roberts DW. Mechanistic applicability domains for nonanimal-based prediction of toxicological end points: general principles and application to reactive toxicity. Chem Res Toxicol. 2006;19:1097–1105. doi: 10.1021/tx0601004. [DOI] [PubMed] [Google Scholar]
- 30.Friedman M. Chemistry, biochemistry and safety of acrylamide. A review. J Agric Food Chem. 2003;51:4504–4526. doi: 10.1021/jf030204+. [DOI] [PubMed] [Google Scholar]
- 31.LoPachin RM, Gavin T. Acrylamide-induced nerve terminal damage: relevance to neurotoxic and neurodegenerative mechanisms. J Agric Food Chem. 2008;56:5994–6003. doi: 10.1021/jf703745t. [DOI] [PubMed] [Google Scholar]
- 32.Stedman RL. The chemical composition of tobacco and tobacco smoke. Chem Rev. 1968;68:153–207. doi: 10.1021/cr60252a002. [DOI] [PubMed] [Google Scholar]
- 33.Parzefall W. Minireview on the toxicity of dietary acrylamide. Food Chem Toxicol. 2008;46:1360–1364. doi: 10.1016/j.fct.2007.08.027. [DOI] [PubMed] [Google Scholar]
- 34.Stevens JF, Maier CS. Acrolein: sources, metabolism and biomolecular interactions relevant to human health and disease. Mol Nutr Food Res. 2008;52:7–25. doi: 10.1002/mnfr.200700412. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Butterfield DA, Bader Lange ML, Sultana R. Involvements of the lipid peroxidation product, HNE, in the pathogenesis and progression of Alzheimer’s disease. Biochimica Biophys Acta. 2010;1801:924–929. doi: 10.1016/j.bbalip.2010.02.005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Singh M, Arseneault M, Sanderson T, Murthy V, Ramassamy C. Challenges for research on polyphenols from foods in Alzheimer’s disease: bioavailability, metabolism, and cellular and molecular mechanisms. J Agric Food Chem. 2008;56:4855–4873. doi: 10.1021/jf0735073. [DOI] [PubMed] [Google Scholar]
- 37.Friedman M, Wall JS. Additive linear free-energy relationships in reaction kinetics of amino groups with α,β-unsaturated compounds. J Org Chem. 1966;31:2888–2894. [Google Scholar]
- 38.Seiner DR, LaButti JN, Gates KS. Kinetics and mechanism of protein tyrosine phosphatase 1B inactivation by acrolein. Chem Res Toxicol. 2007;20:1315–1320. doi: 10.1021/tx700213s. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.McGarth CE, Tallman KA, Proter NA, Marnett LJ. Structure-activity analysis of diffusible lipid electrophiles associated with phospholipid peroxidation: 4-hydroxnonenal and 4-oxononenal analogues. Chem Res Toxicol. 2011;24:357–370. doi: 10.1021/tx100323m. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Doorn JA, Petersen DR. Covalent modification of amino acid nucleophiles by the lipid peroxidation products 4-hydroxynonenal and 4-oxo-2-nonenal. Chem Res Toxicol. 2002;15:1445–1450. doi: 10.1021/tx025590o. [DOI] [PubMed] [Google Scholar]
- 41.Doorn JA, Petersen DR. Covalent adduction of nucleophilic amino acids by 4-hydroxy-2-nonenal and 4-oxononenal. Chem-Biol Interact. 2003;143/144:93–100. doi: 10.1016/s0009-2797(02)00178-3. [DOI] [PubMed] [Google Scholar]
- 42.Tanii H, Hashimoto K. Structure-toxicity relationship of acrylates and methacrylates. Toxicol Lett. 1982;11:125–129. doi: 10.1016/0378-4274(82)90116-3. [DOI] [PubMed] [Google Scholar]
- 43.McCarthy TJ, Hayes EP, Schwartz CS, Witz G. The reactivity of selected acrylate esters toward glutathione and deoxyribonucleosides in vitro: structure-activity relationships. Fund Appl Toxicol. 1994;22:543–548. doi: 10.1006/faat.1994.1061. [DOI] [PubMed] [Google Scholar]
- 44.Bohme A, Thaens D, Pascke A, Schuurmann G. Kinetic glutathione chemoassay to quantify thiol reactivity of organic electrophiles – application to α,β-unsturated ketones, acrylates and propiolates. Chem Res Toxicol. 2009;22:742–750. doi: 10.1021/tx800492x. [DOI] [PubMed] [Google Scholar]
- 45.Aldini G, Gamberoni L, Orioli M, Beretta G, Regazzoni L, Facino RM, Carini M. Mass spectrometric characterization of covalent modification of human serum albumin by 4-hydroxy-trans-2-nonenal. J Mass Spec. 2006;41:1149–1161. doi: 10.1002/jms.1067. [DOI] [PubMed] [Google Scholar]
- 46.Friguet B, Stadtman ER, Szweda LI. Modification of glucose-6-phophate dehydrogenase by 4-hydroxy-2-nonenal. J Biol Chem. 1994;269:21639–21643. [PubMed] [Google Scholar]
- 47.Liu Z, Minkler PE, Sayre LM. Mass spectroscopic characterization of protein modification by 4-hydroxy-2-(E)-nonenal. Chem Res Toxicol. 2003;16:901–911. doi: 10.1021/tx0300030. [DOI] [PubMed] [Google Scholar]
- 48.Szweda LI, Uchida K, Tsai L, Stadtman ER. Inactivation of glucose-6-6phophate dehydrogenase by 4-hydroxy-2-nonenal. J Biol Chem. 1993;268:3342–3347. [PubMed] [Google Scholar]
- 49.Uchida K, Stadtman ER. Modification of histidine residues in proteins by reaction with 4-hydroxynonenal. Proc Natl Acad Sci. 1992;89:4544–4548. doi: 10.1073/pnas.89.10.4544. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50.Uchida K, Stadtman ER. Covalent attachment of 4-hydroxynonenal to glyceraldehyde-3-phosphate dehydrogenase. J Biol Chem. 1993;268:6388–6393. [PubMed] [Google Scholar]
- 51.Uchida K, Kanematsu M, Morimitsu Y, Noriko T, Noguchis N, Niki E. Acrolein is product of lipid peroxidation reaction. J Biol Chem. 1998;273:16058–16066. doi: 10.1074/jbc.273.26.16058. [DOI] [PubMed] [Google Scholar]
- 52.Uchida K, Kanematsu M, Sakai K, Matsuda T, Hattori N, Mizuno Y, Suzuki D, Miyata T, Noguchi N, Niki E. Protein-bound acrolein: Potential markers for oxidative stress. Proc Natl Acad Sci. 1998;95:4882–4887. doi: 10.1073/pnas.95.9.4882. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 53.Ishii T, Tatsuda E, Kumazawa S, Nakayama T, Uchida K. Molecular basis of enzyme inactivation by an endogenous electrophile 4-hydroxy-2-nonenal: identification of modification sites in glyceraldehyde-3-phosphate dehydrogenase. Biochemistry. 2003;42:3473–3480. doi: 10.1021/bi027172o. [DOI] [PubMed] [Google Scholar]
- 54.Aldini G, Dalle-Donne I, Vitoli G, Facino RM, Carini M. Covalent modification of actin by 4-hydroxy-trans-2-nonenal (HNE): LC-ESI-MS/MS evidence for Cys374 Michael adduction. J Mass Spec. 2005;40:946–954. doi: 10.1002/jms.872. [DOI] [PubMed] [Google Scholar]
- 55.Dalle-Donne I, Vistoli G, Gamberoni L, Giustarini D, Colmbo R, Facino RM, Rossi R, Milzani A, Aldini G. Actin Cys374 as a nucleophilic target of α,β-unsaturated aldehydes. Free Rad Biol Med. 2007;42:583–598. doi: 10.1016/j.freeradbiomed.2006.11.026. [DOI] [PubMed] [Google Scholar]
- 56.LoPachin RM, Barber DS, He D, Das S. Acrylamide inhibits dopamine uptake in rat striatal synaptic vesicles. Tox Sci. 2006;89:224–234. doi: 10.1093/toxsci/kfj005. [DOI] [PubMed] [Google Scholar]
- 57.Van Iersel MLPS, Ploemen JPHTM, LoBello M, Federici G, van Bladeren PJ. Interactions of α,β-unsaturated aldehydes and ketones with human glutathione S-transferase P1-1. Chem-Biol Inter. 1997;108:67–78. doi: 10.1016/s0009-2797(97)00096-3. [DOI] [PubMed] [Google Scholar]
- 58.Friedman M, Cavins JF, Wall JS. Relative nucleophilic reactivities of amino groups and mercaptide ions in addition reactions with α,β-unsaturated compounds. J Am Chem Soc. 1965;87:3672–3682. [Google Scholar]
- 59.LoPachin RM, Barber DS. Synaptic cysteine sulfhydryl groups as targets of electrophilic neurotoxicants. Tox Sci. 2006;94:240–255. doi: 10.1093/toxsci/kfl066. [DOI] [PubMed] [Google Scholar]
- 60.Cai J, Bhatnagar A, Pierce WM. Protein modification by acrolein: formation and stability of cysteine adducts. Chem Res Toxicol. 2009;22:708–716. doi: 10.1021/tx800465m. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 61.Feng Y, Forgac M. Cysteine 254 of the 73-kDa A subunit is responsible for inhibition of the coated vesicle (H+)-ATPase upon modification by sulfhydryl reagents. J Biol Chem. 1992;267:5817–5822. [PubMed] [Google Scholar]
- 62.Fritz KS, Galligan JJ, Smathers RL, Roede JR, Shearn CT, Peigan P, Petersen DR. 4-Hydroxynonenal inhibits SIRT3 via thiol-specific modification. Chem Res Toxicol. 2011;24:651–662. doi: 10.1021/tx100355a. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 63.Mercer WD, Winn SI, Watson HC. Twinning in crystals of human skeletal muscle D-glyceraldehyde-3-phophate dehydrogenase. J Mol Biol. 1976;104:277–283. doi: 10.1016/0022-2836(76)90013-9. [DOI] [PubMed] [Google Scholar]
- 64.Thomas JA, Poland B, Hanzatka R. Protein sulfhydryls and their role in the antioxidant function of protein S-thiolation. Arch Biochem Biophys. 1995;319:1–9. doi: 10.1006/abbi.1995.1261. [DOI] [PubMed] [Google Scholar]
- 65.LoPachin RM, Gavin T, Barber DS. Type-2 alkenes mediate synaptotoxicity in neurodegenerative diseases. NeuroToxicology. 2008;29:871–882. doi: 10.1016/j.neuro.2008.04.016. [DOI] [PubMed] [Google Scholar]
- 66.Beauchamp RO, Andjelkovich DA, Kligerman AD, Morgan KT, Heck Hd’A. A critical review of the literature on acrolein toxicity. Crit Rev Toxicol. 1985;14:309–380. doi: 10.3109/10408448509037461. [DOI] [PubMed] [Google Scholar]
- 67.Kehrer JP, Biswal SS. The molecular effects of acrolein. Toxicol Sci. 2000;57:6–15. doi: 10.1093/toxsci/57.1.6. [DOI] [PubMed] [Google Scholar]
- 68.Barber DS, Hunt JR, Ehrich M, Lehning EJ, LoPachin RM. Metabolism, toxicokinetics and hemoglobin adduct formation in rats following subacute and subchronic acrylamide dosing. NeuroToxicology. 2001;22:341–353. doi: 10.1016/s0161-813x(01)00024-9. [DOI] [PubMed] [Google Scholar]
- 69.Miller MJ, Carter DE, Sipes IG. Pharmacokinetics of acrylamide in Fisher-334 rats. Toxicol Appl Pharmacol. 1982;63:36–44. doi: 10.1016/0041-008x(82)90024-2. [DOI] [PubMed] [Google Scholar]
- 70.Green MA, Egle JL. The effects of acetaldehyde and acrolein on blood pressure in guanethidine-pretreated hypertensive rats. Toxicol Appl Pharmacol. 1983;69:29–34. doi: 10.1016/0041-008x(83)90115-1. [DOI] [PubMed] [Google Scholar]
- 71.LoPachin RM, Ross JF, Reid ML, Dasgupta S, Mansukhani S, Lehning EJ. Neurological evaluation of toxic axonopathies in rats: acrylamide and 2,5-hexanedione. NeuroToxicology. 2002;23:95–110. doi: 10.1016/s0161-813x(02)00003-7. [DOI] [PubMed] [Google Scholar]
- 72.Zhang L, Gavin T, Barber DS, LoPachin RM. Role of the Nrf2-ARE pathway in acrylamide neurotoxicituy. Toxicol Letters. 2010;205:1–7. doi: 10.1016/j.toxlet.2011.04.011. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 73.Calakos N, Scheller RH. Synaptic vesicle biogenesis, docking and fusion: A molecular description. Physiol Rev. 1996;76:1–29. doi: 10.1152/physrev.1996.76.1.1. [DOI] [PubMed] [Google Scholar]
- 74.Hatcher H, Planalp R, Cho J, Torti FM, Torti SV. Curcumin: from ancient medicine to current clinical trials. Cell Mol Life Sci. 2008;65:1631–1652. doi: 10.1007/s00018-008-7452-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 75.Mandel S, Youdim MBH. Catechin polyphenols: neurodegeneration and neuroprotection in neurodegenerative diseases. Free Rad Biol Med. 2004;37:304–317. doi: 10.1016/j.freeradbiomed.2004.04.012. [DOI] [PubMed] [Google Scholar]
- 76.Lim GP, Chu T, Yang F, Beech W, Frautschy SA, Cole GM. The curry spice curcumin reduces oxidative damage and amyloid pathology in an Alzheimer trangenic mouse. J Neurosci. 2001;21:8370–8377. doi: 10.1523/JNEUROSCI.21-21-08370.2001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 77.Liu Y, Dargusch R, Maher P, Schubert D. A broadly neuroprotective derivative of curcumin. J Neurochem. 2008;105:1336–1345. doi: 10.1111/j.1471-4159.2008.05236.x. [DOI] [PubMed] [Google Scholar]
- 78.Kim J, Lee HJ, Lee KW. Naturally occurring phytochemicals for the prevention of Alzheimer’s disease. J Neurochem. 2010;112:1415–1430. doi: 10.1111/j.1471-4159.2009.06562.x. [DOI] [PubMed] [Google Scholar]
- 79.Awasthi S, Srivatava SK, Piper JT, Singhal SS, Chaubey M, Awasthi Y. Curcumin protects against 4-hydroxy-2-nonenal-induced cataract formation in rat lenses. Am J Clin Nutr. 1996;64:761–766. doi: 10.1093/ajcn/64.5.761. [DOI] [PubMed] [Google Scholar]
- 80.Jiao Y, Wilkinson J, Pietsch EC, Buss JL, Wang W, Planalp R, Torti FM, Torti SV. Iron chelation in the biological activity of curcumin. Free Rad Biol Med. 2006;40:1152–1160. doi: 10.1016/j.freeradbiomed.2005.11.003. [DOI] [PubMed] [Google Scholar]
- 81.Zhu Q, Zheng Z, Cheng MK, Wu J, Zhang S, Tang YS, Sze K, Chen J, Chen F, Wang M. Natural polyphenols as direct trapping agents of lipid peroxidation-derived acrolein and 4-hydroxy-2-nonenal. Chem Res Toxicol. 2009;22:1721–1729. doi: 10.1021/tx900221s. [DOI] [PubMed] [Google Scholar]
- 82.Begum AN, Jones MR, Lim GP, Morihara T, Kim P, Heath DD, Rock CL, Pruitt MA, Yang R, Hudspeth B, Hu S, Faull KF, Teter B, Cole GM, Frautschy SA. Curcumin structure-function, bioavailability and efficacy in models of neuroinflammation and Alzheimer’s disease. J Pharmacol Exp Ther. 2008;326:196–208. doi: 10.1124/jpet.108.137455. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 83.Vajragupta O, Boonchoong P, Morris GM, Olson AJ. Active site binding modes of curcumin in HIV-1 protease and integrase. Bioorg Med Chem Lett. 2005;15:3364–3368. doi: 10.1016/j.bmcl.2005.05.032. [DOI] [PubMed] [Google Scholar]
- 84.Weber WM, Hunsaker LA, Gonzales AM, Heynekamp JJ, Orlando RA, Deck LM, Vander Jagt DL. TPA-induced up-regulation of activator protein-1 can be inhibited or enhanced by analogs of the natural product curcumin. Biochem Pharmacol. 2006;72:928–940. doi: 10.1016/j.bcp.2006.07.007. [DOI] [PubMed] [Google Scholar]
- 85.Galati G, O’Brien PJ. Potential toxicity of flavonoids and other dietary phenolics: significance for their chemopreventive and anticancer properties. Free Rad Biol Med. 2004;37:287–303. doi: 10.1016/j.freeradbiomed.2004.04.034. [DOI] [PubMed] [Google Scholar]
- 86.Lambert SD, Sang S, Yang CS. Possible controversy over dietary polyphenols: benefits vs risks. Chem Res Toxicol. 2007;20:583–585. doi: 10.1021/tx7000515. [DOI] [PubMed] [Google Scholar]
- 87.LoPachin RM, Gavin T, Geohagen BC, Zhang L, Casper D, Lekhraj R, Barber DS. β-Dicarbonyl enolates: a new class of neuroprotectants. J Neurochem. 2011;116:132–143. doi: 10.1111/j.1471-4159.2010.07091.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 88.Zhang L, Gavin T, DeCaprio AP, LoPachin RM. γ-Diketone axonopathy: analyses of cytoskeletal motors and highways in CNS myelinated axon. Toxicol Sci. 2010;117:180–189. doi: 10.1093/toxsci/kfq176. [DOI] [PMC free article] [PubMed] [Google Scholar]
